3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Neoplasms by Site
3
Colorectal Neoplasms
3
Neoplasms, Glandular and Epithelial
2
Neoplasms by Histologic Type
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Thymus Neoplasms
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Respiratory Tract Neoplasms
1
Rectal Diseases
1
Pancreatic Neoplasms
1
Pancreatic Diseases
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Endocrine System Diseases
1
Endocrine Gland Neoplasms
1
Colonic Diseases
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Hepatocellular
1
Bronchial Neoplasms
1
Advanced Gastrointestinal Cancer
1
Interventions
Everolimus
4
Temozolomide
3
Octreotide
2
Capecitabine
2
Bevacizumab
2
temsirolimus
1
regorafenib
1
pazopanib
1
motesanib diphosphate
1
folfirinox
1
cixutumumab
1
batifiban
1
Sunitinib
1
Sorafenib
1
Sirolimus
1
Oxaliplatin
1
Leucovorin
1
Granulocyte Colony-Stimulating Factor
1
Fluorouracil
1
Filgrastim
1
Fentanyl
1
Doxorubicin
1
Cytokines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Islet Cell
×
napabucasin
×
Clear all
No trials found.